Hepatitis B core antigen expression pattern reflects the response to anti-viral treatment

Journal of Gastroenterology and Hepatology (Australia)

Volumn 21, Issue 6, 2006, Pages 977-981

  Uzun, Yusuf ^a   Bozkaya, Hakan ^b   Erden, Esra ^b   Cinar, Kubilay ^b   Idilman, Ramazan ^b   Yurdaydin, Cihan ^b   Uzunalimoglu, Ozden ^b  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

Chronic hepatitis B; HBcAg; Interferon; Lamivudine; PCNA

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIVIRUS AGENT; CYCLINE; HEPATITIS B CORE ANTIGEN; INTERFERON; LAMIVUDINE; VIRUS DNA;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBROSIS; HEPATITIS B; HEPATITIS B VIRUS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LABELING INDEX; LIVER; LIVER CELL; MALE; PRIORITY JOURNAL;

EID: 33744743797     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04263.x     Document Type: Article

References (22)

1. Lok ASF Heathcote EJ Hoofnagle JH. Management of hepatitis B 2000, summary of a workshop. Gastroenterology 2001 120:1828 53.
2. Perillo RP. Overview of treatment of hepatitis B: key approaches and clinical challenges. Semin. Liver Dis. 2004 24 Suppl. 1 23 9.
3. Fung SK Lok AS. Treatment of chronic hepatitis B: who to treat, what to use, and for how long? Clin. Gastroenterol. Hepatol. 2004 3:839 48.
4. Perrillo RP. Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease. Gastroenterology 2001 120:1009 22.
5. Chisari FV Ferrari C. Hepatitis B virus immunopathogenesis. Ann. Rev. Immunol. 1995 13:29 60.
6. Ozer A Khaoustov VI Mearns M et al. Effect of hepatocyte proliferation and cellular DNA synthesis on hepatitis B virus replication. Gastroenterology 1996 110:1519 28.
7. Serinoz E Varli M Erden E et al. Nuclear localization of hepatitis B core antigen and its relations to liver injury, hepatocyte proliferation, and viral load. J. Clin. Gastroenterol. 2003 36:269 72.
8. Chu CM Liaw YF. Intrahepatic distribution of hepatitis B surface and core antigens in chronic hepatitis B virus infection. Hepatocyte with cytoplasmic/membranous hepatitis B core antigen as a possible target for immune hepatocytolysis. Gastroenterology 1987 92:220 5.
9. Yoo JY Howard R Hoofnagle JH. Peroxidase-anti-peroxidase detection of hepatitis B surface and core antigen in liver biopsy specimens from patients with chronic type B hepatitis. J. Med. Virol. 1987 23:273 81.
10. Yeh CT Wong SW Fung YK et al. Cell cycle regulation of nuclear localization of hepatitis B virus core protein. Proc. Natl Acad. Sci. USA 1993 90:6459 63.
11. Chu CM Yeh CT Sheen IS et al. Subcellular localization of hepatitis B core antigen in relation to hepatocyte regeneration in chronic hepatitis B. Gastroenterology 1995 109:1926 32.
12. Mondelli M Tedder RS Ferns B et al. Differential distribution of hepatitis B core and e antigens in hepatocytes: analysis by monoclonal antibodies. Hepatology 1986 2:199 204.
13. Chu CM Liaw YF. Immunohistological study of intrahepatic expression of hepatitis B core and e antigens in chronic type B hepatitis. J. Clin. Pathol. 1992 45:791 5.
14. Yurdaydin C Bozkaya H Cetinkaya H et al. Lamivudine vs lamivudine and interferon combination treatment of HBeAg (-) chronic hepatitis B. J. Viral Hepat. 2005 12:262 8.
15. Knodell RG Ishak KC Black WC et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981 1:431 5.
16. Kann M Gerlich H. Replication of hepatitis B virus. In:Harrison TJ Zuckerman AJ, eds. The Molecular Medicine of Viral Hepatitis. London:John Wiley & Son, 1997 63 87.
17. Chu CM Yeh CT Chien RN et al. The degrees of hepatocyte nuclear but not cytoplasmic expression of hepatitis B core antigen reflects the level of viral replication in chronic hepatitis B virus infection. J. Clin. Microbiol. 1997 35:102 5.
18. Sansonno DE Fiore G Bufano G et al. Cytoplasmic localization of hepatitis B core antigen in hepatitis B virus infected livers. J. Immunol. Methods 1988 109:245 52.
19. Wieland SF Eustaquio A Whitten-Bauer C Boyd B Chisari FV. Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids. Proc. Natl Acad. Sci. USA 2005 102:9913 17.
20. Guidotti LG Chisari FV. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu. Rev. Immunol. 2001 19:65 91.
21. Lau GK Piratvisuth T Luo KX et al. Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B. N. Engl. J. Med. 2005 352:2682 95.
22. Janssen HL van Zonneveld M Senturk H et al. Rotterdam Foundation for liver research. Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial. Lancet 2005 365:123 9.